Abiopharma

🔍 Dykema John Nicholas (Director)

Company: NICOLET BANKSHARES INC (NIC)

Report Date: 2026-04-14

Detailed Transactions and Holdings:

• Acquired 6 shares of Common Stock at $158.42 per share (Direct)
  Date: 2026-04-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 9,671.24 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-14 | Code: H | shares_owned_after: 43,881.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By the John Dykema 2020 Trust | shares_owned_after: 9,793.00

Footnotes:

• F1: Mr. Dykema acquired 6.356 shares in the Nicolet National Bank Deferred Compensation Plan for Non-employee Directors by deferring his first quarter 2026 earned board fees.
• F2: Includes 20.386 shares received as dividend reinvestment in the Nicolet National Bank Deferred Compensation Plan for Non-employee Directors from Nicolet Bankshares, Inc. paid cash dividend on March 16, 2026.